摘要
目的:了解注射用头孢曲松钠在临床的合理使用情况,尤其是与含钙制剂合并使用的情况。方法:通过HIS获取2010年3月30日我院所有使用注射用头孢曲松钠的患者的信息,并查阅这些患者的病历。结果:2.58%(55/2134)的住院患者使用了注射用头孢曲松钠;23.64%(13/55)的病例使用了4g日剂量,且采用了"每日二次,每次2g"的给药方法;55个病例平均用药持续时间为5.33天,有5例超过10天;15例(占27.27%)在接受头孢曲松钠治疗期间合并使用了含钙制剂。结论:注射用头孢曲松钠在临床使用中存在给药方法不正确、用药持续时间长和不适宜的联合用药情况。
Objective： To understand the rational medication of ceftriaxone sodium injection during clinical therapy, especially the medication combined with calcium preparation. Methods： Obtain the information of in-patients who used ceftriaxone sodium injection in March 30, 2010 from HIS of our hospital, and refer to the medical records of these patients. Results： 2.58% （55/2,134） in-patients used ceftriaxone sodium for injection. 23.64% （13/55） inpatients＇ daily dosage was 4 g, and the administration was ＂twice a day, 2 g each time＂ . The average duration of using drug was 5.33 days, but 5 cases were above 10 days. 15 in-patients used calcium preparation when they were administrated ceftriaxone sodium injection. Conclusion： There are some in correction in clinical use of ceftriaxone sodium injection, such as： wrong administration, long-duration and unsuitable medication combined with other drugs, especially calcium preparation.
出处
《药品评价》
CAS
2010年第14期24-28,36,共6页
Drug Evaluation
关键词
头孢曲松钠
含钙制剂
合理用药
Ceflriaxone
Calcium Preparation
Rational medication
